20.07.2016 18:25:26
|
Valeant Pharmaceuticals Holding On To Notable Gain After Initial Jump
(RTTNews) - After seeing initial strength, Valeant Pharmaceuticals (VRX) continues to turn in a strong performance in afternoon trading on Wednesday. Valeant is currently up by 4.8 percent after reaching its highest level in over a month.
Valeant has benefited from a positive reaction to news that the FDA has approved Relistor tablets for the treatment of opioid-induced constipation. A FDA committee also recommended approval of Valeant's Brodalumab for treatment of moderate-to-severe plaque psoriasis.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Valeant Pharmaceuticals Internationalmehr Nachrichten
Keine Nachrichten verfügbar. |